Education
About Us
Working with TipRanks
Follow Us
Guardian Pharmacy Services, Inc. Class A (GRDN)
NYSE:GRDN
GRDN Stock Chart & Stats
$31.15
$0.47(2.39%)
At close: 4:00 PM EST
$31.15
$0.47(2.39%)
Day’s Range― - ―
52-Week Range$17.78 - $37.43
Previous Close$20.98
Volume93.63K
Average Volume (3M)348.83K
Market Cap
$1.94B
Enterprise Value$1.63B
Total Cash (Recent Filing)$36.49M
Total Debt (Recent Filing)$34.08M
Price to Earnings (P/E)48.9
Beta0.63
Next Earnings
Apr 01, 2026EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.25
Shares Outstanding36,253,742
10 Day Avg. Volume450,542
30 Day Avg. Volume348,833
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)8.81
Price to Sales (P/S)1.02
P/FCF Ratio30.20
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit5.93
Enterprise Value/Ebitda19.80
Forecast
1Y Price Target
$34.50Price Target Upside10.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Guardian Pharmacy Services, Inc. Class A News
GRDN FAQ
What was Guardian Pharmacy Services, Inc. Class A’s price range in the past 12 months?
Guardian Pharmacy Services, Inc. Class A lowest stock price was $17.78 and its highest was $37.43 in the past 12 months.
What is Guardian Pharmacy Services, Inc. Class A’s market cap?
Guardian Pharmacy Services, Inc. Class A’s market cap is $1.94B.
When is Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date?
Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date is Apr 01, 2026 which is in 102 days.
How were Guardian Pharmacy Services, Inc. Class A’s earnings last quarter?
Guardian Pharmacy Services, Inc. Class A released its earnings results on Nov 10, 2025. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.235 by $0.015.
Is Guardian Pharmacy Services, Inc. Class A overvalued?
According to Wall Street analysts Guardian Pharmacy Services, Inc. Class A’s price is currently Undervalued.
Does Guardian Pharmacy Services, Inc. Class A pay dividends?
Guardian Pharmacy Services, Inc. Class A does not currently pay dividends.
What is Guardian Pharmacy Services, Inc. Class A’s EPS estimate?
Guardian Pharmacy Services, Inc. Class A’s EPS estimate is 0.27.
How many shares outstanding does Guardian Pharmacy Services, Inc. Class A have?
Guardian Pharmacy Services, Inc. Class A has 36,253,742 shares outstanding.
What happened to Guardian Pharmacy Services, Inc. Class A’s price movement after its last earnings report?
Guardian Pharmacy Services, Inc. Class A reported an EPS of $0.25 in its last earnings report, beating expectations of $0.235. Following the earnings report the stock price went up 5.042%.
Which hedge fund is a major shareholder of Guardian Pharmacy Services, Inc. Class A?
Currently, no hedge funds are holding shares in GRDN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Guardian Pharmacy Services, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.50 (10.75% Upside)
$34.50 (10.75% Upside)
Hedge Fund Trend
Increased
By 62.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $25.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.50%
12-Months-Change
Fundamentals
Return on Equity
25.85%
Trailing 12-Months
Asset Growth
12.07%
Trailing 12-Months
Company Description
Guardian Pharmacy Services, Inc. Class A
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
GRDN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Guardian Pharmacy reported strong financial growth and increased guidance for the year, driven by successful acquisitions and organic growth. However, regulatory challenges and the dilutive impact of recent acquisitions present ongoing challenges. The positive financial performance and strategic expansions are tempered by these operational and external pressures.View all GRDN earnings summariesGRDN Stock 12 Month Forecast
Average Price Target
$34.50
▲(10.75% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---